Repligen
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Seyon St Building 41 1 Ste 100, Waltham,...Phone Number
(781) 250-0111Website
www.repligen.comRevenue
$763.3 MillionStock Symbol
RGENIndustry
ZI Rank: 3
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
5
4
1
2
3
About Repligen
Founded in 1981 and headquartered in Waltham, Massachusetts, Repligen is a bioprocessing-focused life sciences company that is inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.Explore more
Repligen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Repligen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Repligen had a recent Job posting/layoffs
Repligen, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Repligen has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Repligen has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Repligen recently announced quarterly report
Check out if Repligen is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Repligen
Product Launch: Get notified when Repligen launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Repligen
Compare insights from companies similar to Repligen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Repligen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Repligen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Repligen.
Repligen Tech Stack
A closer look at the technologies used by Repligen
Most Recent Scoops
Person-Based
Stake & Stock Ownership, Finance
Hiring Plans
Repligen has more open roles in Engineering & Technical than it has had at any time in the past 12 months with an increased focus on technologies like JavaScript, PHP, Postman, Pimcore, Docker, Adobe, and Symfony. Areas of expertise include: Full Stack Development, Sitecore (Software), Web Performance Optimization, Localization, Mvc.net, Web Application Development, and Analytics.
Hiring Plans
Project
Repligen has announced plans to consolidate its 17 manufacturing sites down to 8 to 10 designated future sites, with all new investment to be directed exclusively to those sites and simultaneous work underway to shut down the remaining locations over the next few years.
Spending/Investment, Shut Down, Manufacturing Operations
Project
Repligen has announced plans to launch a new version of its small-scale tangential flow filtration (TFF) system, targeting an installed base of several thousand units, with the launch expected next year.
Earnings
Repligen News & Media
Is Repligen Corporation (RGEN) A Good Stock To Buy Now?
Is RGEN a good stock to buy? We came across a bullish thesis on Repligen Corporation on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on RGEN. Repligen Corporation’s share was trading at $136.44 as of June 30th. RGEN’s trailing and forward P/E were 149.86 and 68.97 respectively according to Yahoo […]Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools
Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its “Osterweis Opportunity Fund”. A copy of the letter can be downloaded here. The fund returned -3.78% in the quarter compared to -2.81% for the Russell 2000 Growth Index. The fund’s long-term returns stay positive, but recent geopolitical shocks and AI […]Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair 46th Annual Growth Stock Conference in Chicago, IL. Olivier Loeillot, President and Chief Executive Officer, will present a company overview on June 3rd at 10:40 a.m. CT.Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate Sustainability Report and related reporting framework disclosures. Themed “Driving Sustainable Growth Together”, this report communicates the company’s progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply C
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Repligen
Sign Up For FreeTo access detailed company insights
Founded in 1981 and headquartered in Waltham, Massachusetts, Repligen is a bioprocessing-focused life sciences company that is inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.... Read More
